Home/Filings/4/0000899243-22-039012
4//SEC Filing

Harrison Rosemary 4

Accession 0000899243-22-039012

CIK 0001750019other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 5:13 PM ET

Size

7.9 KB

Accession

0000899243-22-039012

Insider Transaction Report

Form 4
Period: 2022-12-15
Harrison Rosemary
Chief Business & Strategy
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-15+76,93076,930 total
    Exercise: $0.97Exp: 2032-12-14Common Stock (76,930 underlying)
  • Award

    Restricted Stock Unit (Right to Buy)

    2022-12-15+12,82212,822 total
    Common Stock (12,822 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
  • [F2]Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
  • [F3]The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1
  • filerCIK 0001838046

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:13 PM ET
Size
7.9 KB